DJIA 18,037.97 -42.17 -0.23%
NASDAQ 5,060.25 -31.84 -0.63%
S&P 500 2,108.92 -8.77 -0.41%
market minute promo

Exelixis (NASDAQ: EXEL)

2.83 -0.25 (-8.12%)

REAL-TIME: Last trade at

Extended Hours: $2.83 $0.00 (0.00%)
Quote as of (NASDAQ)



company name or ticker

Recent Quotes

EXEL $2.83 -8.12%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.10
Previous Close $3.08
Daily Range $2.77 - $3.11
52-Week Range $1.26 - $4.55
Market Cap $554.4M
P/E Ratio -2.23
Dividend (Yield) $0.00 (0.0%)
Volume 3,308,914
Average Daily Volume 2,805,425
Current FY EPS -$0.86

Sector

Healthcare

Industry

Drug Makers

Exelixis (EXEL) Description

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases. Website: http://www.exelixis.com/

News & Commentary

3 Soaring Biotech Stocks Under $10 -- Are They Buys?

Here's what you should know about Exelixis Inc., Corcept Therapeutics, and Array BioPharma's big moves this year.

Will Epizyme (EPZM) Beat Estimates This Earnings Season? - Analyst Blog

Biotech Investors: May 29th Could Be A Big Day

Exelixis (EXEL) Shares March Higher, Can It Continue? - Tale of the Tape

Exelixis (EXEL) Shares March Higher, Can It Continue? - Tale of the Tape

The Zacks Analyst Blog Highlights: Rigel Pharmaceuticals, Exelixis and Atlas Resource Partners - Pre

The Zacks Analyst Blog Highlights: Rigel Pharmaceuticals, Exelixis and Atlas Resource Partners - Press Releases

Best Pure Play Investment in Cancer Drugs

Global cancer drug sales could soon soar past $100 billion, making this pure play in cancer drugs a stock you should seriously consider owning.

3 Momentum Picks Under $10 to Sail the Turbulent Market - Analyst Blog

Exelexis (EXEL) Is The 'Chart of the Day'

3 Biotech Stocks That May Disappear Before 2020

Our experts weigh in.

2 Speculative Biotechs That Could Be Well Worth the Risk

Celladon Corp. and Exelixis Inc. are two speculative biotech stocks that might be worth their substantial risks.

See More EXEL News...

EXEL's Top Competitors

EXEL $2.83 (-8.12%)
Current stock: EXEL
TMO $127.27 (-2.12%)
Current stock: TMO
ILMN $183.71 (-3.10%)
Current stock: ILMN
WAT $122.00 (-1.25%)
Current stock: WAT